Costa, Diego Luís 
; Amaral, Eduardo P.; Namasivayam, Sivaranjani; Mittereder, Lara R.; Andrade, Bruno B.; Sher, Alan
Source: Frontiers in Cellular and Infection Microbiology. Unidade: FMRP
Subjects: AGENTES ANTIMICROBIANOS, ANTÍGENOS DE BACTÉRIAS, MYCOBACTERIUM TUBERCULOSIS, TUBERCULOSE, VACINAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Diego Luís et al. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work?. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.672527. Acesso em: 27 jan. 2026.APA
Costa, D. L., Amaral, E. P., Namasivayam, S., Mittereder, L. R., Andrade, B. B., & Sher, A. (2021). Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? Frontiers in Cellular and Infection Microbiology, 11, 1-12. doi:10.3389/fcimb.2021.672527NLM
Costa DL, Amaral EP, Namasivayam S, Mittereder LR, Andrade BB, Sher A. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-12.[citado 2026 jan. 27 ] Available from: https://doi.org/10.3389/fcimb.2021.672527Vancouver
Costa DL, Amaral EP, Namasivayam S, Mittereder LR, Andrade BB, Sher A. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-12.[citado 2026 jan. 27 ] Available from: https://doi.org/10.3389/fcimb.2021.672527
